Innoviva, Inc.
INVA
$22.16
-$0.71-3.08%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 42.83M | 59.72M | 47.90M | 36.40M | 30.83M |
| Total Other Revenue | 55.17M | 54.90M | 59.90M | 63.88M | 57.81M |
| Total Revenue | 97.99M | 114.61M | 107.80M | 100.28M | 88.63M |
| Cost of Revenue | 14.46M | 36.18M | 35.69M | 10.59M | 8.60M |
| Gross Profit | 83.54M | 78.43M | 72.11M | 89.69M | 80.03M |
| SG&A Expenses | 32.44M | 32.08M | 27.41M | 26.41M | 27.49M |
| Depreciation & Amortization | 6.55M | 6.64M | 6.62M | 6.55M | 6.48M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.69M | 74.89M | 69.72M | 51.53M | 46.96M |
| Operating Income | 39.30M | 39.72M | 38.08M | 48.75M | 41.67M |
| Income Before Tax | 234.56M | 195.04M | 97.82M | 72.60M | -38.59M |
| Income Tax Expenses | 47.97M | 30.88M | 7.91M | 8.91M | 8.00M |
| Earnings from Continuing Operations | 186.60M | 164.15M | 89.91M | 63.69M | -46.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 186.60M | 164.15M | 89.91M | 63.69M | -46.58M |
| EBIT | 39.30M | 39.72M | 38.08M | 48.75M | 41.67M |
| EBITDA | 45.89M | 46.39M | 44.73M | 55.33M | 48.18M |
| EPS Basic | 2.52 | 2.19 | 1.30 | 1.01 | -0.74 |
| Normalized Basic EPS | 0.37 | 0.35 | 0.35 | 0.48 | 0.40 |
| EPS Diluted | 2.22 | 1.94 | 1.08 | 0.77 | -0.74 |
| Normalized Diluted EPS | 0.33 | 0.31 | 0.29 | 0.36 | 0.40 |
| Average Basic Shares Outstanding | 74.16M | 74.80M | 69.06M | 62.87M | 62.71M |
| Average Diluted Shares Outstanding | 84.85M | 85.26M | 84.96M | 84.45M | 62.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |